MariMed Inc. (OTCMKTS:MRMD) Short Interest Down 45.2% in April

MariMed Inc. (OTCMKTS:MRMD) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 36,003 shares, a decline of 45.2% from the March 31st total of 65,750 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 1,232,829 shares, the days-to-cover ratio is currently 0.0 days.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of MariMed from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

MariMed Stock Performance

Shares of OTCMKTS:MRMD traded up $0.00 during midday trading on Wednesday, reaching $0.09. The company had a trading volume of 1,421,239 shares, compared to its average volume of 563,306. The company’s 50 day moving average price is $0.08 and its 200 day moving average price is $0.09. The company has a current ratio of 1.00, a quick ratio of 0.38 and a debt-to-equity ratio of 1.44. The stock has a market cap of $36.42 million, a P/E ratio of -3.04 and a beta of 1.15. MariMed has a 52-week low of $0.06 and a 52-week high of $0.23.

About MariMed

MariMed Inc is a multi?state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult?use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre?rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.